Screening period (4 weeks) | Treatment period (0 to 24 months) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day 0 | Week 4 | Week 8 | Week 12 | Week 20 | Week 29 | Week 38 | Week 47 | Week 60 | Week 73 | Week 86 | Week 104 | ||
(± 2 days) | (± 2 days) | (± 2 days) | (± 5 days) | (± 5 days) | (± 5 days) | (± 5 days) | (± 10 days) | (± 10 days) | (± 10 days) | (± 10 days) | |||
Visit | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |
Informed consent | x | ||||||||||||
Inclusion/exclusion criteria | x | x | |||||||||||
Randomization | x | ||||||||||||
Medical history | x | x | |||||||||||
Concomitant medication | x | x | x | x | x | x | x | x | x | x | x | x | |
Physical examination | x | x | |||||||||||
Body weight and height | x | x | |||||||||||
Vital signs (BP, PR) | x | x | x | x | x | x | x | x | x | x | x | x | |
Laboratory test | x | x | x | x | x | x | x | x | x | x | x | x | x |
Laboratory test: bone markers | x | x | x | ||||||||||
Biobank sample | x | x | x | x | x | ||||||||
Urinalysis | x | x | x | x | x | x | x | x | x | x | x | x | x |
24-hour urine collection | xa | xa | x | x | x | x | |||||||
Urine pregnancy test b | x | x | x | x | x | x | x | x | x | x | x | x | |
Adverse events | x | x | x | x | x | x | x | x | x | x |